US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 11, 2018 (8 years ago)

Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.

What was recalled

Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For: TORRENT PHARMA INC., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920. NDC: 13668-342-30

Recalling firm
Torrent Pharma Inc.
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1204-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lamotrigine recalls

See all